Targeting NR4A1 (TR3) in cancer cells and tumors

Bibliography

• Gronemeyer H, Gustafsson JA, Laudet V. Principles for modulation of the nuclear receptor superfamily. Nat Rev Drug Discov 2004;3:950-64
   PubMed Web of Science ®Google Scholar
• McKenna NJ, Cooney AJ, DeMayo FJ, Minireview: evolution of NURSA, the nuclear receptor signaling atlas. Mol Endocrinol 2009;23:740-6
   PubMedGoogle Scholar
• Benoit G, Cooney A, Giguere V, International Union of Pharmacology. LXVI. Orphan nuclear receptors. Pharmacol Rev 2006;58:798-836
   PubMed Web of Science ®Google Scholar
• Bookout AL, Jeong Y, Downes M, Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 2006;126:789-99
   PubMed Web of Science ®Google Scholar
• Shi Y. Orphan nuclear receptors in drug discovery. Drug Discov Today 2007;12:440-5
   PubMed Web of Science ®Google Scholar
• Paulsen RF, Granas K, Johnsen H, Three related brain nuclear receptors, NGFI-B, Nurr1, and NOR-1, as transcriptional activators. J Mol Neurosci 1995;6:249-55
   PubMed Web of Science ®Google Scholar
• Murphy EP, Dobson AD, Keller C, Differential regulation of transcription by the NURR1/NUR77 subfamily of nuclear transcription factors. Gene Expr 1996;5:169-79
   PubMed Web of Science ®Google Scholar
• Saucedo-Cardenas O, Kardon R, Ediger TR, Cloning and structural organization of the gene encoding the murine nuclear receptor transcription factor, NURR1. Gene 1997;187:135-9
   PubMed Web of Science ®Google Scholar
• Maxwell MA, Muscat GE. The NR4A subgroup: immediate early response genes with pleiotropic physiological roles. Nucl Recept Signal 2006;4:e002
   PubMedGoogle Scholar
• Pearen MA, Muscat GE. Minireview: nuclear hormone receptor 4A signaling: implications for metabolic disease. Mol Endocrinol 2010;24:1891-903
   PubMed Web of Science ®Google Scholar
• Zhang XK. Targeting Nur77 translocation. Expert Opin Ther Targets 2007;11:69-79
   PubMed Web of Science ®Google Scholar
• Cho SD, Lee SO, Chintharlapalli S, Activation of nerve growth factor-induced Balpha by methylene-substituted diindolylmethanes in bladder cancer cells induces apoptosis and inhibits tumor growth. Mol Pharmacol 2010;77:396-404
   PubMed Web of Science ®Google Scholar
• Cho SD, Yoon K, Chintharlapalli S, Nur77 agonists induce proapoptotic genes and responses in colon cancer cells through nuclear receptor-dependent and independent pathways. Cancer Res 2007;67:674-83
   PubMed Web of Science ®Google Scholar
• Wu H, Lin Y, Li W, Regulation of Nur77 expression by beta-catenin and its mitogenic effect in colon cancer cells. FASEB J 2010: published online 16 September 2010, doi:10.1096/fj.10-166462
   Google Scholar
• Lee SO, Abdelrahim M, Yoon K, Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth. Cancer Res 2010;70:6824-36
   PubMed Web of Science ®Google Scholar
• Holmes WF, Soprano DR, Soprano KJ. Comparison of the mechanism of induction of apoptosis in ovarian carcinoma cells by the conformationally restricted synthetic retinoids CD437 and 4-HPR. J Cell Biochem 2003;89:262-78
   PubMed Web of Science ®Google Scholar
• Holmes WF, Soprano DR, Soprano KJ. Early events in the induction of apoptosis in ovarian carcinoma cells by CD437: activation of the p38 MAP kinase signal pathway. Oncogene 2003;22:6377-86
   PubMed Web of Science ®Google Scholar
• Shin HJ, Lee BH, Yeo MG, Induction of orphan nuclear receptor Nur77 gene expression and its role in cadmium-induced apoptosis in lung. Carcinogenesis 2004;25:1467-75
   PubMed Web of Science ®Google Scholar
• Wu Q, Liu S, Ye XF, Dual roles of Nur77 in selective regulation of apoptosis and cell cycle by TPA and ATRA in gastric cancer cells. Carcinogenesis 2002;23:1583-92
   PubMed Web of Science ®Google Scholar
• Milbrandt J. Nerve growth factor induces a gene homologous to the glucocorticoid receptor gene. Neuron 1988;1:183-8
   PubMed Web of Science ®Google Scholar
• Wu Q, Dawson MI, Zheng Y, Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids. Mol Cell Biol 1997;17:6598-608
   PubMed Web of Science ®Google Scholar
• Li QX, Ke N, Sundaram R, NR4A1, 2, 3 – an orphan nuclear hormone receptor family involved in cell apoptosis and carcinogenesis. Histol Histopathol 2006;21:533-40
   PubMed Web of Science ®Google Scholar
• Ke N, Claassen G, Yu DH, Nuclear hormone receptor NR4A2 is involved in cell transformation and apoptosis. Cancer Res 2004;64:8208-12
   PubMed Web of Science ®Google Scholar
• Alexopoulou AN, Leao M, Caballero OL, Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines. Breast Cancer Res 2010;12:R51
   PubMed Web of Science ®Google Scholar
• Uemura H, Chang C. Antisense TR3 orphan receptor can increase prostate cancer cell viability with etoposide treatment. Endocrinology 1998;139:2329-34
   PubMed Web of Science ®Google Scholar
• Bras A, Albar JP, Leonardo E, Ceramide-induced cell death is independent of the Fas/Fas ligand pathway and is prevented by Nur77 overexpression in A20 B cells. Cell Death Differ 2000;7:262-71
   PubMed Web of Science ®Google Scholar
• Kolluri SK, Bruey-Sedano N, Cao X, Mitogenic effect of orphan receptor TR3 and its regulation by MEKK1 in lung cancer cells. Mol Cell Biol 2003;23:8651-67
   PubMed Web of Science ®Google Scholar
• Zeng H, Qin L, Zhao D, Orphan nuclear receptor TR3/Nur77 regulates VEGF-A-induced angiogenesis through its transcriptional activity. J Exp Med 2006;203:719-29
   PubMed Web of Science ®Google Scholar
• Azoitei N, Pusapati GV, Kleger A, Protein kinase D2 is a crucial regulator of tumour cell-endothelial cell communication in gastrointestinal tumours. Gut 2010;59:1316-1330
   PubMed Web of Science ®Google Scholar
• Chen GQ, Lin B, Dawson MI, Nicotine modulates the effects of retinoids on growth inhibition and RARbeta expression in lung cancer cells. Int J Cancer 2002;99:171-8
   PubMed Web of Science ®Google Scholar
• Wu Q, Li Y, Liu R, Modulation of retinoic acid sensitivity in lung cancer cells through dynamic balance of orphan receptors nur77 and COUP-TF and their heterodimerization. EMBO J 1997;16:1656-69
   PubMed Web of Science ®Google Scholar
• Ramaswamy S, Ross KN, Lander ES, A molecular signature of metastasis in primary solid tumors. Nat Genet 2003;33:49-54
   PubMed Web of Science ®Google Scholar
• Cao X, Liu W, Lin F, Retinoid X receptor regulates Nur77/TR3-dependent apoptosis [corrected] by modulating its nuclear export and mitochondrial targeting. Mol Cell Biol 2004;24:9705-25
   PubMed Web of Science ®Google Scholar
• Dawson MI, Hobbs PD, Peterson VJ, Apoptosis induction in cancer cells by a novel analogue of 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid lacking retinoid receptor transcriptional activation activity. Cancer Res 2001;61:4723-30
   PubMed Web of Science ®Google Scholar
• Li H, Kolluri SK, Gu J, Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science 2000;289:1159-64
   PubMedGoogle Scholar
• Li Y, Lin B, Agadir A, Molecular determinants of AHPN (CD437)-induced growth arrest and apoptosis in human lung cancer cell lines. Mol Cell Biol 1998;18:4719-31
   PubMed Web of Science ®Google Scholar
• Lin B, Kolluri SK, Lin F, Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 2004;116:527-40
   PubMed Web of Science ®Google Scholar
• Kolluri SK, Zhu X, Zhou X, A short Nur77-derived peptide converts Bcl-2 from a protector to a killer. Cancer Cell 2008;14:285-98
   PubMed Web of Science ®Google Scholar
• Ferlini C, Cicchillitti L, Raspaglio G, Paclitaxel directly binds to Bcl-2 and functionally mimics activity of Nur77. Cancer Res 2009;69:6906-14
   PubMed Web of Science ®Google Scholar
• Jeong JH, Park JS, Moon B, Orphan nuclear receptor Nur77 translocates to mitochondria in the early phase of apoptosis induced by synthetic chenodeoxycholic acid derivatives in human stomach cancer cell line SNU-1. Ann NY Acad Sci 2003;1010:171-7
   PubMed Web of Science ®Google Scholar
• Wilson AJ, Arango D, Mariadason JM, TR3/Nur77 in colon cancer cell apoptosis. Cancer Res 2003;63:5401-7
   PubMed Web of Science ®Google Scholar
• Lee JM, Lee KH, Weidner M, Epstein-Barr virus EBNA2 blocks Nur77- mediated apoptosis. Proc Natl Acad Sci USA 2002;99:11878-83
   PubMed Web of Science ®Google Scholar
• Lee JM, Lee KH, Farrell CJ, EBNA2 is required for protection of latently Epstein-Barr virus-infected B cells against specific apoptotic stimuli. J Virol 2004;78:12694-7
   PubMed Web of Science ®Google Scholar
• Lee KW, Ma L, Yan X, Rapid apoptosis induction by IGFBP-3 involves an insulin-like growth factor-independent nucleomitochondrial translocation of RXR/Nur77. J Biol Chem 2005;280:16942-8
   PubMed Web of Science ®Google Scholar
• Gennari A, Bleumink R, Viviani B, Identification by DNA macroarray of nur77 as a gene induced by di-n-butyltin dichloride: its role in organotin-induced apoptosis. Toxicol Appl Pharmacol 2002;181:27-31
   PubMed Web of Science ®Google Scholar
• Chinnaiyan P, Varambally S, Tomlins SA, Enhancing the antitumor activity of ErbB blockade with histone deacetylase (HDAC) inhibition. Int J Cancer 2006;118:1041-50
   PubMed Web of Science ®Google Scholar
• Chen YL, Jian MH, Lin CC, The induction of orphan nuclear receptor Nur77 expression by n-butylenephthalide as pharmaceuticals on hepatocellular carcinoma cell therapy. Mol Pharmacol 2008;74:1046-58
   PubMed Web of Science ®Google Scholar
• Liu J, Zhou W, Li SS, Modulation of orphan nuclear receptor Nur77-mediated apoptotic pathway by acetylshikonin and analogues. Cancer Res 2008;68:8871-80
   PubMed Web of Science ®Google Scholar
• Liu JJ, Zeng HN, Zhang LR, A unique pharmacophore for activation of the nuclear orphan receptor Nur77 in vivo and in vitro. Cancer Res 2010;70:3628-37
   PubMed Web of Science ®Google Scholar
• Zhan Y, Du X, Chen H, Cytosporone B is an agonist for nuclear orphan receptor Nur77. Nat Chem Biol 2008;4:548-56
   PubMed Web of Science ®Google Scholar
• Lin XF, Zhao BX X, Chen HZ, RXRalpha acts as a carrier for TR3 nuclear export in a 9-cis retinoic acid-dependent manner in gastric cancer cells. J Cell Sci 2004;117:5609-21
   PubMed Web of Science ®Google Scholar
• Katagiri Y, Takeda K, Yu ZX, Modulation of retinoid signalling through NGF-induced nuclear export of NGFI-B. Nat Cell Biol 2000;2:435-40
   PubMed Web of Science ®Google Scholar
• Han YH, Cao X, Lin B, Regulation of Nur77 nuclear export by c-Jun N-terminal kinase and Akt. Oncogene 2006;25:2974-86
   PubMed Web of Science ®Google Scholar
• Chen HZ, Zhao BX, Zhao WX, Akt phosphorylates the TR3 orphan receptor and blocks its targeting to the mitochondria. Carcinogenesis 2008;29:2078-88
   PubMed Web of Science ®Google Scholar
• Yang H, Bushue N, Bu P, Induction and intracellular localization of Nur77 dictate fenretinide-induced apoptosis of human liver cancer cells. Biochem Pharmacol 2010;79:948-54
   PubMed Web of Science ®Google Scholar
• Chen L, Hu L, Chan TH, Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1l) gene suppresses the nucleus-to-mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival. Hepatology 2009;50:122-9
   PubMed Web of Science ®Google Scholar
• Chen L, Yuan YF, Li Y, Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion. Gut 2010: published online 10 November 2010, doi:10.1136/gut.2010.224071
   Google Scholar
• Safe S, Papineni S, Chintharlapalli S. Cancer chemotherapy with indole-3-carbinol, bis(3′-indolyl)methane and synthetic analogs. Cancer Lett 2008;269:326-38
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Ichikawa H. Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell Cycle 2005;4:1201-15
   PubMed Web of Science ®Google Scholar
• Le HT, Schaldach CM, Firestone GL, Plant-derived 3,3′-diindolylmethane is a strong androgen antagonist in human prostate cancer cells. J Biol Chem 2003;278:21136-45
   PubMed Web of Science ®Google Scholar
• Shilling AD, Carlson DB, Katchamart S, 3,3′-diindolylmethane, a major condensation product of indole-3-carbinol, is a potent estrogen in the rainbow trout. Toxicol Appl Pharmacol 2001;170:191-200
   PubMed Web of Science ®Google Scholar
• Chen I, Safe S, Bjeldanes L. Indole-3-carbinol and diindolylmethane as aryl hydrocarbon (Ah) receptor agonists and antagonists in T47D human breast cancer cells. Biochem Pharmacol 1996;51:1069-76
   PubMed Web of Science ®Google Scholar
• Chen I, McDougal A, Wang F, Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane. Carcinogenesis 1998;19:1631-9
   PubMed Web of Science ®Google Scholar
• Bjeldanes LF, Kim JY, Grose KR, Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo – comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proc Natl Acad Sci USA 1991;88:9543-7
   PubMed Web of Science ®Google Scholar
• Qin C, Morrow D, Stewart J, A new class of peroxisome proliferator-activated receptor gamma (PPAR gamma) agonists that inhibit growth of breast cancer cells: 1,1-bis(3′-indolyl)-1-(p-substitutedphenyl)methanes. Mol Cancer Ther 2004;3:247-59
   PubMed Web of Science ®Google Scholar
• Chintharlapalli S, Smith R III, Samudio I, 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes induce peroxisome proliferator-activated receptor gamma-mediated growth inhibition, transactivation and differentiation markers in colon cancer cells. Cancer Res 2004;64:5994-6001
   PubMed Web of Science ®Google Scholar
• Hong J, Samudio I, Liu S, Peroxisome proliferator-activated receptor gamma-dependent activation of p21 in Panc-28 pancreatic cancer cells involves Sp1 and Sp4 proteins. Endocrinology 2004;145:5774-85
   PubMed Web of Science ®Google Scholar
• Chintharlapalli S, Papineni S, Baek SJ, 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes are peroxisome proliferator-activated receptor gamma agonists but decrease HCT-116 colon cancer cell survival through receptor-independent activation of early growth response-1 and NAG-1. Mol Pharmacol 2005;68:1782-92
   PubMed Web of Science ®Google Scholar
• Kassouf W, Chintharlapalli S, Abdelrahim M, Inhibition of bladder tumor growth by 1,1-bis(3′-indolyl)-1-(p-substitutedphenyl)methanes: a new class of peroxisome proliferator-activated receptor gamma agonists. Cancer Res 2006;66:412-18
   PubMed Web of Science ®Google Scholar
• Chintharlapalli S, Papineni S, Safe S. 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through PPARgamma-dependent and PPARgamma-independent pathways. Mol Cancer Ther 2006;5:1362-70
   PubMed Web of Science ®Google Scholar
• Chintharlapalli S, Papineni S, Safe S. 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes inhibit growth, induce apoptosis, and decrease the androgen receptor in LNCaP prostate cancer cells through peroxisome proliferator-activated receptor gamma-independent pathways. Mol Pharmacol 2007;71:558-69
   PubMed Web of Science ®Google Scholar
• Su Y, Vanderlaag K, Ireland C, 1,1-Bis(3′-indolyl)-1-(p-biphenyl)methane inhibits basal-like breast cancer growth in athymic nude mice. Breast Cancer Res 2007;9:R56
   Google Scholar
• York M, Abdelrahim M, Chintharlapalli S, 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes induce apoptosis and inhibit renal cell carcinoma growth. Clin Cancer Res 2007;13:6743-52
   PubMed Web of Science ®Google Scholar
• Vanderlaag K, Su Y, Frankel AE, 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways. Breast Cancer Res Treat 2008;109:273-83
   PubMed Web of Science ®Google Scholar
• Ichite N, Chougule MB, Jackson T, Enhancement of docetaxel anticancer activity by a novel diindolylmethane compound in human non-small cell lung cancer. Clin Cancer Res 2009;15:543-52
   PubMed Web of Science ®Google Scholar
• Guo J, Chintharlapalli S, Lee SO, Peroxisome proliferator-activated receptor gamma-dependent activity of indole ring-substituted 1,1-bis(3′-indolyl)-1-(p-biphenyl)methanes in cancer cells. Cancer Chemother Pharmacol 2010;66:141-50
   PubMed Web of Science ®Google Scholar
• Lei P, Abdelrahim M, Safe S. 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes inhibit ovarian cancer cell growth through peroxisome proliferator-activated receptor-dependent and independent pathways. Mol Cancer Ther 2006;5:2324-36
   PubMed Web of Science ®Google Scholar
• Lei P, Abdelrahim M, Cho SD, 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through activation of c-Jun N-terminal kinase. Carcinogenesis 2008;29:1139-47
   PubMed Web of Science ®Google Scholar
• Lei P, Abdelrahim M, Cho SD, Structure-dependent activation of endoplasmic reticulum stress-mediated apoptosis in pancreatic cancer by 1,1-bis(3′-indoly)-1-(p-substituted phenyl)methanes. Mol Cancer Ther 2008;7:3363-72
   PubMed Web of Science ®Google Scholar
• Abdelrahim M, Newman K, Vanderlaag K, 3,3′-Diindolylmethane (DIM) and derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5. Carcinogenesis 2006;27:717-28
   PubMed Web of Science ®Google Scholar
• Contractor R, Samudio I, Estrov Z, A novel ring-substituted diindolylmethane 1,1-bis[3′-(5-methoxyindolyl)]-1-(p-t-butylphenyl)methane inhibits ERK activation and induces apoptosis in acute myeloid leukemia. Cancer Res 2005;65:2890-8
   PubMed Web of Science ®Google Scholar
• Sohn YC, Kwak E, Na Y, Silencing mediator of retinoid and thyroid hormone receptors and activating signal cointegrator-2 as transcriptional coregulators of the orphan nuclear receptor Nur77. J Biol Chem 2001;276:43734-9
   PubMed Web of Science ®Google Scholar
• Chintharlapalli S, Burghardt R, Papineni S, Activation of Nur77 by selected 1,1-bis(3′-indolyl)-1-(p-substituted phenyl)methanes induces apoptosis through nuclear pathways. J Biol Chem 2005;280:24903-14
   PubMed Web of Science ®Google Scholar
• Maira M, Martens C, Batsche E, Dimer-specific potentiation of NGFI-B (Nur77) transcriptional activity by the protein kinase A pathway and AF-1-dependent coactivator recruitment. Mol Cell Biol 2003;23:763-76
   PubMed Web of Science ®Google Scholar
• Philips A, Lesage S, Gingras R, Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells. Mol Cell Biol 1997;17:5946-51
   PubMed Web of Science ®Google Scholar
• Cho SD, Lei P, Abdelrahim M, 1,1-Bis(3′-indolyl)-1-(p-methoxyphenyl)methane activates Nur77-independent proapoptotic responses in colon cancer cells. Mol Carcinog 2008;47:252-63
   PubMed Web of Science ®Google Scholar
• Lee SO, Chintharlapalli S, Liu S, p21 Expression is induced by activation of nuclear nerve growth factor-induced Balpha (NGFI-Balpha, Nur77) in pancreatic cancer cells. Mol Cancer Res 2009;7:1169-78
   PubMed Web of Science ®Google Scholar
• Liu M, Iavarone A, Freedman LP. Transcriptional activation of the human p21(WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. J Biol Chem 1996;271:31723-8
   PubMed Web of Science ®Google Scholar
• Owen GI, Richer JK, Tung L, Progesterone regulates transcription of the p21WAF1 cyclin-dependent kinase inhibitor gene through Sp1 and CBP/p300. J Biol Chem 1998;273:10696-701
   PubMed Web of Science ®Google Scholar
• Lu S, Jenster G, Epner DE. Androgen induction of cyclin-dependent kinase inhibitor p21 gene: role of androgen receptor and transcription factor Sp1 complex. Mol Endocrinol 2000;14:753-60
   PubMedGoogle Scholar
• Stein RA, Gaillard S, McDonnell DP. Estrogen-related receptor alpha induces the expression of vascular endothelial growth factor in breast cancer cells. J Steroid Biochem Mol Biol 2009;114:106-12
   PubMed Web of Science ®Google Scholar
• Stein RA, Chang CY, Kazmin DA, Estrogen-related receptor alpha is critical for the growth of estrogen receptor-negative breast cancer. Cancer Res 2008;68:8805-12
   PubMed Web of Science ®Google Scholar
• Chisamore MJ, Wilkinson HA, Flores O, Estrogen-related receptor-alpha antagonist inhibits both estrogen receptor-positive and estrogen receptor-negative breast tumor growth in mouse xenografts. Mol Cancer Ther 2009;8:672-81
   PubMed Web of Science ®Google Scholar
• Pennati M, Folini M, Zaffaroni N. Targeting survivin in cancer therapy: fulfilled promises and open questions. Carcinogenesis 2007;28:1133-9
   PubMed Web of Science ®Google Scholar
• Stauber RH, Mann W, Knauer SK. Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential. Cancer Res 2007;67:5999-6002
   PubMed Web of Science ®Google Scholar
• Chadalapaka G, Jutooru I, Chintharlapalli S, Curcumin decreases specificity protein expression in bladder cancer cells. Cancer Res 2008;68:5345-54
   PubMed Web of Science ®Google Scholar
• Jutooru I, Chadalapaka G, Lei P, Inhibition of NFκB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein downregulation. J Biol Chem 2010;285:25332-44
   PubMed Web of Science ®Google Scholar